News: Daniel Beauchamp

Oncology Named Among Nation’s Best

Friday, March 23rd, 2012

Becker’s Hospital Review has named Vanderbilt University Medical Center to its list of 70 Hospitals and Health Systems with Great Oncology Programs. These hospitals are deemed to be on the cutting edge of cancer treatment, prevention and research, and the Becker’s Hospital Review editorial team selected them based on clinical accolades, quality care and contributions […]

Colon Cancer’s Cellular Crossroads

Friday, March 16th, 2012

Colon cancer development and progression involves alterations in several cell signaling pathways. Activation of the Wnt pathway is involved in the early stages of tumor development, while inactivation of signaling through the TGF-beta pathway (which typically suppresses tumor formation) is involved in later stages. However, the interactions between these pathways remain unclear. R. Daniel Beauchamp, […]

Heart Protein May be Target for Colon Cancer Therapies

Friday, October 7th, 2011

A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators fromVanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) – which also is key in regulating corneal cells – may be a therapeutic target for halting colon cancer metastasis. The study, […]

Heart Protein Has Role in Colon Cancer

Tuesday, September 13th, 2011

A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial substance) – which also is key in regulating corneal cells – may be a therapeutic target for halting colon […]